Tue09292020

Robins Global News & Noticias



COVID-19 Map Tracker | COVID-19 News Features


  • Career Exam Study
    Career Exam Study
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News

RobinsPost News Network

+ Larger Font | - Smaller Font
Share

feed-image RSS

Globe NewsWire News Distribution Service

GlobeNewswire and Intrado form a single worldwide news distribution service with expertise in multiple continents, helping public and private companies communicate with media and investors in local languages. Publicly traded companies can now seamlessly address their regulatory disclosure requirements in markets throughout the world. Learn more about GlobeNewsWire.com here.

RobinsPost partnered with Globe Newswire when it used to be owend by NASDAQ, to bring you the latest industry information from top companies. This partnership brought valuable information to help consumers receive the best product and news data on the web. The partnership was formed on September 14th, 2015.

NASDAQ YouTube Channel




Press Release: Conagen Wins SynBioBeta Award for Non-GMO Human Milk Oligosaccharide and Human Lactoferrin


Bedford, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- SynBioBeta’s (SBB) Synthetic Biology Global Conference awarded Conagen the “Best Product of the Year” for its human lactoferrin and non-GMO human milk oligosaccharide (HMO.)

Human lactoferrin is a critical iron-binding compound for immunity and iron nutrition. HMOs are important nutritional compounds only found in human milk. The most abundant HMO in human milk is 2’-fucosyllactose (2’FL), and it is responsible for promoting good gut bacteria, strengthening the gut barrier function, and suppressing pathogens.

“Conagen is honored to accept this award from SynBioBeta for our human lactoferrin and non-GMO HMO infant formula ingredients, but we do not intend to stop there. We are dedicated to continuously improving infant health and nutrition by expanding our portfolio with many more innovative infant formula ingredients,” said VP of Innovation, Dr. Casey Lippmeier.

In addition to their human lactoferrin and non-GMO HMO and products, Conagen is the first company to commercialize an odorless and tasteless butyrate releaser, otherwise known as FBA. FBA delivers butyrate, a short-chain fatty acid that helps infants develop gut and immune systems for mitigating a number of pathologies, including common food allergies to cow’s milk(1). It is an important health postbiotic and probiotic molecule for building gut health and immunity.

While Conagen’s FBA has been licensed in the infant formula space, there are partnership opportunities still available in applications spanning food and beverage, medical nutrition, dietary supplements, and pharmaceuticals.

“Today we are announcing our third offering for infant formula fortification, a compound which delivers butyrate to the infant gut in a way which safely conveys its important, well-characterized post-biotic effects, while retaining the accepted flavor of formula for babies’ palates,” said Lippmeier.

About Conagen

Conagen is making the impossible possible. Our scientists and engineers use the latest synthetic biology tools to develop high-quality sustainable nature-based products through systems of manufacturing on a molecular level and fermentation basis. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. For more information, visit www.conagen.com

Reference (1):Canani, Roberto Berni, et al. "Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants." The ISME journal 10.3 (2016): 742-750.

###

Attachment

Ana Arakelian
Conagen
Office: +1-781-271-1588 and Cell: +1.781.353.9028
This email address is being protected from spambots. You need JavaScript enabled to view it.

Read more ...

Press Release: FactSet lancerer dækning af danske realkreditobligationer


NORWALK, Conn., ob København, Sept. 29, 2020 (GLOBE NEWSWIRE) -- FactSet (NYSE:FDS) (NASDAQ:FDS), en global udbyder af integreret finansiel information, analytiske applikationer og brancheførende services, meddeler, at de har lanceret data og analyseredskaber for danske realkreditobligationer på tværs af alle deres distributionskanaler, herunder FactSet workstation. Virksomheden har indgået et samarbejde med Scanrate, en førende udbyder af software, modeller og data til det danske obligationsmarked, om at levere øget dækning på det danske marked.

“Danmark er et af de sikreste ejendomsmarkeder i verden, og vi ser allerede efterspørgsel fra obligationskunder, der efterspørger mere fleksible investeringer i jagten på afkast” siger Carl Cedstrand, Vice President and Regional Director, UK and Nordics, FactSet. “Vi leverer et unikt datasæt takket være vores samarbejde med Scanrate, som er en af ​​de eneste virksomheder, der tilbyder så detaljeret dækning af det danske obligationsunivers.”

En tredjedel af det danske obligationsmarked på godt 4.100 mia. DKK består af 20 til 30-årige fastforrentede realkreditobligationer, hvor låntagerne har en konverteringsret meget lig tilsvarende fastforrentede realkreditobligationer udstedt i USA. I modsætning til europæisk statsgæld og de obligationer, der forventes udstedt af Den Europæiske Union, som for det meste tilbyder negative afkast, indeholder de AAA-ratede danske realkreditobligationer stadig interessante afkastpotentialer for investorer, der er i stand til at analysere og håndtere den potentielle konverteringsrisiko. Derfor er den udenlandske beholdning af danske fastforrentede realkreditobligationer fordoblet i løbet af de seneste fem år og den udgør nu 34 pct. af det samlede udestående.

Tilføjelsen af Scanrate til FactSet betyder, at kunder kan få adgang til:

  • Referencedata, historiske udtræk og markedskurser for det fulde danske obligationsunivers;
  • Dagligt opdaterede konverterings- og værdiansættelsesmodeller, der dækker alle aspekter af det danske obligationsmarked;
  • Optionsjusterede risikomål, delta- og gammavektorer;
  • Forventede cash flows, scenarianalyser;
  • Performance attribution.

”Scanrates modeller kan bruges til både den daglige rapportering og interaktive analyser” siger Svend Jakobsen, CEO, Scanrate. ”Integrationen med FactSets værktøjer giver dig mulighed for at analysere, hvordan risiko- og afkast for danske realkreditobligationer passer ind i din globale renteportefølje.”

For mere information, besøg venligst:
https://www.factset.com/solutions/business-needs/portfolio-analytics/portfolio-analytics eller https://www.scanrate.dk/.

Om FactSet

FactSet® (NYSE:FDS | NASDAQ:FDS) leverer førende indhold, analyseredskaber og en fleksibel teknologi, der hjælper mere end 131.000 brugere med at se og gribe mulighederne hurtigere. Vi giver investeringsfagfolk indsigt til at slå konkurrenterne, workflow-løsninger på tværs af porteføljens livscyklus og brancheførende support fra dedikerede specialister. Vi er stolte over at være blevet anerkendt med flere priser for vores analytiske og datadrevne løsninger og har gentagne gange opnået 100 på Human Rights Campaign® Corporate Equality Index for vores LGBTQ + -omfattende politikker og praksisser. Abonner på vores blog om thought leadership for at få frisk indsigt leveret dagligt på insight.factset.com. Lær mere på www.factset.com og følg os på Twitter: www.twitter.com/factset.

Om Scanrate

Scanrate Financial Systems A/S blev grundlagt i 1986 og er et privatejet dansk firma, der leverer software til obligationsanalyse, reference data og markedsværdiopgørelser. Scanrate har udviklet konverterings- og værdiansættelsesmodeller, der i vid udstrækning anvendes som benchmark for det danske obligationsmarked og leverer det fulde spektrum af analyseredskaber, der er nødvendige til risiko- og afkastmåling samt regulativ rapportering. Kunder inkluderer centralbanker, banker, formueforvaltere og leverandører af finansiel data. 

 

Read more ...

More Articles ...



Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2020 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources:
Bing News, Google News, Faroo News, NewsApi.org and YouTube Search Results.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.